| PERIOD ENDING | 3-Jan-09 | 29-Dec-07 | 30-Dec-06 | | Total Revenue | 135,878 | 156,281 | 138,465 | | Cost of Revenue | 110,415 | 120,343 | 103,882 | | | Gross Profit | 25,463 | 35,938 | 34,584 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 18,433 | 20,009 | 18,790 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 7,030 | 15,929 | 15,794 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 35 | 205 | 149 | | Earnings Before Interest And Taxes | 7,065 | 16,134 | 15,944 | | Interest Expense | 1,064 | 1,289 | 1,098 | | Income Before Tax | 6,002 | 14,845 | 14,846 | | Income Tax Expense | 1,538 | 4,765 | 5,187 | | Minority Interest | 41 |
-
|
-
| | | | Net Income From Continuing Ops | 4,505 | 10,081 | 9,659 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 4,505 | 10,081 | 9,659 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,505 | $10,081 | $9,659 |
|
0.51% Nasdaq 
0.19 (1.53%) 
Income Statement
